AI assistant
EXELIXIS, INC. — Director's Dealing 2021
Jan 15, 2021
30561_dirs_2021-01-14_ddae3ba6-cab1-45b8-a045-41cc762d058b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2021-01-12
Reporting Person: Senner Christopher J. (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-12 | Common Stock | M | 30000 | $3.66 | Acquired | 275596 | Direct |
| 2021-01-12 | Common Stock | S | 30000 | $25 | Disposed | 245596 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-12 | Option (right to buy) | $3.66 | M | 30000 | Disposed | 2022-07-14 | Common Stock (30000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2723 | Indirect |
Footnotes
F1: Includes 117,410 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2020
F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 11, 2021.
F4: The option, representing the right to purchase a total of 350,000 shares of Exelixis, Inc. common stock, became fully exercisable on July 15, 2019